• Trial(s) for Transplantation

    Study Objective Contact
    A 24 Month, Randomized, Controlled, Study to Evaluate the Efficacy and Safety of Concentration-Controlled Everolimus Plus Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplants [LCID Study Number: 2014-032] Study to Evaluate the Efficacy and Safety of Concentration-Controlled Everolimus Plus Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplants Principal Investigator(s):
    Elizabeth A. Pomfret, MD, PhD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Agnes P. Trabucco,
    Erick Marangos.
    A Multi-Center, Randomized, Prospective Open- Label Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Hepatitis C Immune Globulin (HCIG) in Orthotopic Liver Transplant Recipients [LCID Study Number: 2014-023] This purpose of this study is to test the safety of different doses of the investigational therapy Hepatitis C Immune Globulin (HCIG) when given to patients with Hepatitis-C (HCV) who undergo liver transplantation. Principal Investigator(s):
    Fredric D. Gordon, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Agnes P. Trabucco,
    Erick Marangos.
    A Prospective Investigation Of Quality Of Life In Live Liver Donors [LCID Study Number: 2001-019] Questionnaire study of quality of life in live liver transplant donors Principal Investigator(s):
    Elizabeth A. Pomfret, MD, PhD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Agnes P. Trabucco,
    Erick Marangos.
  • Make An Appointment

    (781) 744-2500
  • HRSA Award

    Health Resources and Services Administration (HRSA) Awards Lahey Clinic the Silver1 Medal of Honor for Organ Donation.